Atlas Trials

Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)

Clinical trial NCT05831007 · UNKNOWN

Trial details

NCT number
NCT05831007
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2021-12-06
Primary completion
2023-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.